...
首页> 外文期刊>Oncogene >Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase|[sol]|cGMP pathway in human ovarian cancer cells
【24h】

Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase|[sol]|cGMP pathway in human ovarian cancer cells

机译:可溶性鸟苷基环化酶| [sol] | cGMP途径对人卵巢癌细胞中p53的调控和凋亡的抑制

获取原文

摘要

Dysregulated apoptosis plays a critical role in the development of a number of aberrant cellular processes, including tumorigenesis and chemoresistance. However, the mechanisms that govern the normal apoptotic program are not completely understood. Soluble guanylyl cyclase (sGC) and cyclic guanosine monophosphate (cGMP) promote mammalian cell viability via an unknown mechanism and p53 status is a key determinant of cell fate in human ovarian cancer cells. Whether an interaction exists between these two determinants of cell fate is unknown. We hypothesized that basal sGC activity reduces p53 content and attenuates p53-dependent apoptosis in human ovarian cancer cells. Suppression of sGC activity with the specific inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) lowered cGMP content, and increased p53 protein content and induced apoptosis in three ovarian cancer cell lines, effects which were attenuated by the cGMP analog 8-Br-cGMP and by Atrial Natriuretic Factor, an activator of particulate guanylyl cyclase, which circumvent the inhibition of sGC. ODQ prolonged p53 half-life, induced phosphorylation of p53 on Ser15, and upregulated the p53-dependent gene products p21, murine double minute-2, and the proapoptotic, p53-responsive gene product Bax. ODQ activated caspase-3, and ODQ-induced apoptosis was inhibited by overexpression of X-linked inhibitor of apoptosis Protein. Pretreatment with the specific p53 inhibitor pifithrin or downregulation of p53 using a specific small inhibitory RNA significantly attenuated ODQ-induced apoptosis. Moreover, ODQ-induced upregulation of p21 and Bax and ODQ-induced apoptosis were significantly reduced in a p53 mutant cell line relative to the wild-type parental cell line. Thus, the current study establishes that basal sGC/cGMP activity regulates p53 protein stability, content, and function, possibly by altering p53 phosphorylation and stabilization, and promotes cell survival in part through regulation of caspase-3 and p53.
机译:凋亡失调在许多异常细胞过程的发展中起着关键作用,包括肿瘤发生和化学抗性。但是,控制正常凋亡程序的机制尚未完全了解。可溶性鸟苷基环化酶(sGC)和环状鸟苷单磷酸(cGMP)通过未知机制促进哺乳动物细胞的活力,而p53的状态是决定人类卵巢癌细胞命运的关键因素。在细胞命运的这两个决定因素之间是否存在相互作用尚不清楚。我们假设基础sGC活性降低人卵巢癌细胞中p53的含量并减弱p53依赖性细胞凋亡。用特异性抑制剂1H- [1,2,4]恶二唑[4,3-a]喹喔啉-1-酮(ODQ)抑制sGC活性可降低cGMP含量,并增加p53蛋白含量并诱导三个卵巢癌细胞凋亡,通过cGMP类似物8-Br-cGMP和心房利钠因子(一种颗粒鸟苷酰环化酶的激活剂)减弱了其作用,从而避免了sGC的抑制作用。 ODQ延长了p53的半衰期,在Ser15上诱导了p53的磷酸化,并上调了p53依赖性基因产物p21,鼠doubleminute-2和促凋亡,p53反应性基因产物Bax。 ODQ激活caspase-3,并且ODQ诱导的细胞凋亡被X连锁的凋亡蛋白抑制剂过度表达所抑制。用特定的p53抑制剂匹菲菌素预处理或使用特定的小抑制性RNA下调p53可以显着减弱ODQ诱导的细胞凋亡。而且,相对于野生型亲本细胞系,在p53突变细胞系中,ODQ诱导的p21和Bax的上调以及ODQ诱导的凋亡显着降低。因此,当前的研究确定基础sGC / cGMP活性可能通过改变p53的磷酸化和稳定作用来调节p53蛋白的稳定性,含量和功能,并部分地通过调节caspase-3和p53来促进细胞存活。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号